U.S. Media Stock News

In April 2026, Snowflake announced extensive updates to Snowflake Intelligence and Cortex Code, aiming to connect more enterprise data sources, systems, and AI models into a single environment so organizations can run AI agents directly on governed data reflecting how their businesses operate. By positioning these AI agents as a control plane for enterprise workflows and extending Cortex Code across third-party platforms like AWS Glue, Databricks, and Postgres, Snowflake is trying to embed...

First quarter earnings as a fresh signal for Avista stock Avista (AVA) stock is back in focus after first quarter 2026 results showed revenue of US$570 million versus US$617 million a year earlier, while net income reached US$92 million and earnings per share from continuing operations came in at US$1.11. See our latest analysis for Avista. At a share price of US$40.56, Avista has had a 4.75% year to date share price return, while the 1 year total shareholder return is 1.59%. This hints at...

Why Knife River’s latest earnings matter for shareholders Knife River (KNF) reported first quarter revenue of US$410.1 million and a net loss of US$79.2 million, a combination that often prompts investors to reassess how the stock reflects the underlying business. See our latest analysis for Knife River. The earnings update and the recent disclosure that Vanguard Capital Management holds 5.25% of Knife River appear to sit alongside strong recent momentum, with a 30 day share price return of...

Herc Holdings Inc. has already reported first-quarter 2026 results, with sales rising to US$981 million and total revenue to US$1.14 billion, while net loss widened to US$24 million as the company completed integrating H&E Equipment Services and expanded its branch network by 30%. Alongside double-digit specialty revenue growth, record e-commerce revenue, insider share purchases and continued analyst support highlight growing confidence in Herc’s ability to capture benefits from its enlarged...

Inter & Co. Inc. recently attracted attention after analysts projected higher year-over-year earnings and revenue for the March 2026 quarter, with Zacks highlighting an Earnings ESP of 14.00% and a Rank of #2 based on its latest estimate revisions. An interesting angle is that this optimistic earnings setup, centered on expectations of beating consensus EPS, is emerging even as the broader analyst community had already built in ambitious multi-year growth and profitability assumptions for...

Ultra Clean Holdings recently reported first-quarter 2026 results, with revenue rising to US$533.7 million while posting a net loss of US$17.9 million, and concurrently announced the upcoming retirement of CFO Sheri Savage alongside a change in board chair later this month. The company also issued second-quarter guidance calling for higher revenue and a return to GAAP profitability and disclosed new insider trading plans and a Form 144 filing, adding fresh context to its capital structure...

Immunome has submitted a New Drug Application to the FDA for varegacestat, an oral once-daily gamma secretase inhibitor for adults with desmoid tumors, backed by a global Phase 3 RINGSIDE trial that met its primary and key secondary endpoints. A key insight is that RINGSIDE is the largest randomized study conducted in this rare tumor type, with data selected for oral presentation at the 2026 ASCO Annual Meeting, highlighting the clinical community’s interest in varegacestat’s profile. We’ll...

In recent months, multiple law firms have filed securities class action lawsuits against monday.com Ltd., alleging that between September 17, 2025 and February 6, 2026 the company misled investors about its revenue growth outlook, AI-driven expansion, and longer enterprise sales cycles, following reduced guidance and the withdrawal of a previously announced US$1.80 billion 2027 revenue target. These lawsuits raise questions about the transparency and reliability of monday.com’s prior growth...

Las Vegas Sands stock under pressure Las Vegas Sands (LVS) has been under pressure recently, with the stock showing a decline of about 5% over the past month and about 9% over the past three months, prompting investors to reassess expectations. See our latest analysis for Las Vegas Sands. At a share price of $51.86, Las Vegas Sands has seen weaker recent momentum, with a 7 day share price return of 4.79% and a year to date share price return of 20.47%, while the 1 year total shareholder...

L3Harris Technologies (LHX) has drawn fresh attention after reporting first quarter 2026 earnings, with sales of US$5,744 million, higher net income, and raised full year revenue and earnings guidance supported by a record defense backlog. See our latest analysis for L3Harris Technologies. The solid first quarter and raised guidance come after a softer patch in the share price, with a 30-day share price return decline of 13.31% and a 90-day share price return decline of 12.22%, while the...

Recent performance snapshot LGI Homes (LGIH) has moved sharply in recent months, with the stock showing a one month gain of 17.7%, a past 3 months decline of 16.7%, and a 1 year total return decline of 19.8%. See our latest analysis for LGI Homes. At a share price of $44.88, LGI Homes has seen momentum fade recently, with a 1 day share price decline of 7.5% following a 30 day share price gain of 17.7%. The 1 year total shareholder return remains down 19.8%, which points to a stock still...

Trevi Therapeutics recently announced plans to present detailed Phase 2b CORAL trial results and additional nalbuphine ER data for IPF-related chronic cough at the ATS 2026 International Conference in Orlando on May 18, 2026. Alongside upcoming Q1 2026 results and a proposal to double authorized common shares, these scientific disclosures highlight how clinical and corporate actions may shape Trevi’s future options for funding and advancing Haduvio. We’ll now examine how the upcoming Phase...

What Alexander's latest earnings mean for investors Alexander's (ALX) stock was in focus after the REIT reported weaker first quarter results, with lower net income, softer earnings per share, and funds from operations that did not meet analyst expectations. See our latest analysis for Alexander's. Despite the weaker quarter, Alexander's share price has a year to date return of 11.4% and the 1 year total shareholder return of 24.16% suggests momentum has been building over a longer...

Dave (DAVE) heads into its Q1 2026 earnings release and call on May 5 with investors focused on how recent revenue and adjusted EBITDA trends, along with its AI driven credit model, are feeding heightened interest. See our latest analysis for Dave. The share price has surged recently, with a 61.65% 1 month share price return and 64.22% 3 month share price return, while the 1 year total shareholder return of 166.51% points to momentum that has built over time despite a weaker 5 year total...

Harmony Biosciences Holdings (HRMY) is back in focus after fresh analyst commentary highlighted upward revisions to earnings forecasts, stronger projected earnings per share growth, and healthy cash flow supporting the company’s near term prospects. See our latest analysis for Harmony Biosciences Holdings. At a share price of $32.59, Harmony Biosciences has seen short term momentum build, with a 1 month share price return of 17.48% and a 1 week share price return of 4.96%. This comes even...

Stock performance snapshot and recent context PTC Therapeutics (PTCT) has drawn investor attention after recent trading, with the stock last closing at $65.49. The company operates in the rare disease biopharma space, with products spanning Duchenne muscular dystrophy and spinal muscular atrophy. See our latest analysis for PTC Therapeutics. Recent trading has been choppy, with a 1-day share price return of 0.52% compared with a 90-day share price return of 12.48% and a 1-year total...

First BanCorp (FBP) stock is in focus after the company reported first quarter 2026 results, a quarterly dividend declaration, and an update on its ongoing share repurchase activity. See our latest analysis for First BanCorp. At a share price of $23.90, First BanCorp has seen a 9.94% 1 month share price return and a 14.35% year to date share price return, while its 5 year total shareholder return of 123.39% reflects the impact of recent dividend and buyback news. If you are looking beyond...

Leidos Holdings reported past first-quarter 2026 results with sales of US$4,400 million, higher than a year earlier, while net income and earnings per share from continuing operations decreased year on year. Alongside these earnings, Leidos secured multi‑hundred‑million‑dollar U.S. defense and health contracts and maintained its quarterly cash dividend, underscoring the scale of its government-backed backlog. Now we’ll examine how these sizeable new U.S. Army and Military OneSource awards...

Ares Management (ARES) is back in focus after first quarter 2026 results, which combined record fundraising of US$30b, higher fee-related earnings, and an increase of more than 20% in the common dividend. See our latest analysis for Ares Management. The stock has reacted sharply around these updates, with a 17.13% 1 month share price return and 6.95% 7 day share price return. However, a 27.87% year to date share price decline and 22.86% 1 year total shareholder return decline contrast with a...

What Firefly Aerospace’s Recent Performance Tells You Firefly Aerospace (FLY) has drawn investor attention after a strong past 3 months, with the stock returning 33.16%, while month performance sits at 1.34% and year to date at 40.45%. Those moves come alongside reported annual revenue of US$159.86 million and a net loss of US$333.96 million. This highlights a business that is generating sales but still investing heavily, with returns over the past week and day in negative territory. See our...

Gen Digital (GEN) is back on investors’ radar after Norton Neo, its AI-native browser, received a major upgrade integrating VPN, anti-phishing, and anti-fingerprinting protections directly into the browsing experience. See our latest analysis for Gen Digital. Despite a steady run of product news and partnerships around AI and security, Gen Digital’s share price has a 1-day return of 1.34% at US$19.63, with short-term momentum positive. However, the year-to-date share price return shows a...

Group 1 Automotive (GPI) is back in focus after first quarter 2026 results came in below analyst expectations, even as record U.K. gross profits, cost cuts, and continued share repurchases supported overall profitability. See our latest analysis for Group 1 Automotive. The stock has lost momentum recently, with a 1 day share price return of a 6.69% decline and a year to date share price return of a 15.94% decline, while the 5 year total shareholder return of 105.34% still reflects meaningful...

McDonald's (MCD) is in focus as it rolls out six specialty drinks across all U.S. restaurants from May 6, while phasing out self serve soda fountains by 2032 ahead of its next earnings update. See our latest analysis for McDonald's. Despite the buzz around new beverages and restaurant upgrades, the share price has softened, with a 30 day share price return of 7.5% and a 1 year total shareholder return showing a 7.9% decline. However, the 5 year total shareholder return of 34.23% points to...

Context for First Horizon stock First Horizon (FHN) has drawn fresh attention after a recent move in its share price, with the stock closing at US$24.63 and showing mixed returns over the past month and past 3 months. See our latest analysis for First Horizon. For context, this recent pullback follows a 6.3% 1 month share price return, while the stock’s 1 year and 3 year total shareholder returns of 34.5% and over 150% point to momentum that has built over time rather than faded. If First...